Happe Laura E
Journal of Managed Care and Specialty Pharmacy, Alexandria, VA; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville.
J Manag Care Spec Pharm. 2025 Jul;31(7):617-626. doi: 10.18553/jmcp.2025.31.7.617.
This article commemorates the 30th anniversary of the (), reflecting on its evolution to a central voice in managed care pharmacy. Launched in 1995, has chronicled the profession's growth while shaping the national conversation around value, access, and outcomes. The journal's early content addressed educational gaps and shared practical insights from the field, developing over time to feature rigorous health economics and outcomes research studies. and its authors played a pivotal role in elevating real-world evidence, as well as guiding stakeholders through transformative policy shifts like Medicare Part D and the Inflation Reduction Act. Over the years, has delved into complex topics such as management of high-cost drugs, value assessment, equity, and access. Acknowledging its most influential contributors and publications, this article illustrates how has remained a dynamic forum for scholarly dialogue. With an enduring legacy of connecting researchers, practitioners, and policymakers, remains poised to guide managed care pharmacy through future challenges in pursuit of improved patient health through evidence-based decision-making.
本文纪念（）创刊30周年，回顾其发展成为管理式医疗药学核心声音的历程。该期刊于1995年创刊，记录了该专业的发展，同时塑造了围绕价值、可及性和结果的全国性讨论。该期刊早期的内容涉及教育差距，并分享了该领域的实用见解，随着时间的推移，发展为以严谨的卫生经济学和结果研究为特色。该期刊及其作者在提升真实世界证据方面发挥了关键作用，并指导利益相关者应对诸如医疗保险D部分和《降低通胀法案》等变革性政策转变。多年来，该期刊深入探讨了高成本药物管理、价值评估、公平性和可及性等复杂话题。本文认可其最具影响力的贡献者和出版物，阐述了该期刊如何一直是学术对话的活跃平台。凭借连接研究人员、从业者和政策制定者的持久遗产，该期刊仍准备好引导管理式医疗药学应对未来挑战，通过基于证据的决策改善患者健康。
